Related Experiment Video
Updated: Feb 8, 2026

Simultaneous Isolation and Culture of Atrial Myocytes, Ventricular Myocytes, and Non-Myocytes from an Adult Mouse Heart
Published on: June 14, 2020
New Myocyte Formation in the Adult Heart: Endogenous Sources and Therapeutic Implications
Ronald J Vagnozzi1, Jeffery D Molkentin2,3, Steven R Houser4
1From the Department of Pediatrics (R.J.V., J.D.M.).
Insights
Adult heart cells (cardiac myocytes) cannot regenerate after injury. New research suggests focusing on existing myocyte proliferation, not progenitor cells, for heart repair therapies.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Cardiac Pathophysiology
Background:
- Cardiovascular diseases lead to adult cardiac myocyte death, driving pathological ventricular remodeling and heart failure.
- Current therapies, excluding heart transplantation, cannot replace lost cardiac myocytes.
- Limited understanding of endogenous myocyte turnover hinders regenerative strategies for injured hearts.
Purpose of the Study:
- To investigate the cellular sources and intrinsic capacity for endogenous cardiac myocyte turnover in adult mammals.
- To inform the development of innovative therapeutic strategies for cardiac regeneration after injury.
Main Methods:
- Review of existing literature on cardiac myocyte proliferation and progenitor cell activity.
- Analysis of the consensus regarding endogenous mechanisms of myocyte renewal.
Main Results:
- A growing consensus indicates that the limited capacity for new myocyte formation in adult hearts stems from the proliferation of existing cardiac myocytes.
- Evidence does not support the activity of an endogenous progenitor cell source for myocyte regeneration.
Conclusions:
- Future therapeutic approaches for cardiac regeneration must consider the fundamental biology of myocyte renewal, focusing on existing myocyte proliferation.
- Strategies to replenish lost myocytes in injured hearts should be designed based on this understanding of myocyte turnover.
Abstract:
Death of adult cardiac myocytes and supportive tissues resulting from cardiovascular diseases such as myocardial infarction is the proximal driver of pathological ventricular remodeling that often culminates in heart failure. Unfortunately, no currently available therapeutic barring heart transplantation can directly replenish myocytes lost from the injured heart. For decades, the field has struggled to define the intrinsic capacity and cellular sources for endogenous myocyte turnover in pursuing more innovative therapeutic strategies aimed at regenerating the injured heart. Although controversy persists to this day as to the best therapeutic regenerative strategy to use, a growing consensus has been reached that the very limited capacity for new myocyte formation in the adult mammalian heart is because of proliferation of existing cardiac myocytes but not because of the activity of an endogenous progenitor cell source of some sort. Hence, future therapeutic approaches should take into consideration the fundamental biology of myocyte renewal in designing strategies to potentially replenish these cells in the injured heart.
Related Concept Videos
Anatomy of the Heart
Therapeutic Index
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Sinusoidal Sources
In homes, the power supplies use sinusoidal sources to provide electricity. These sources generate a voltage that varies sinusoidally...
AC Sources
Sources of Law
Constitutional law is foundational, deriving from federal and state constitutions, and...

